Administration of Yunnan Baiyao or Xingnaojing in Patients With Moderate-to-Severe Traumatic Brain Injury and Craniotomy
Copyright © Targeted News Service 2026
2026-03-24
ALEXANDRIA, Virginia, March 24 -- LOTUS BIOTECH.COM LLC, Gaithersburg, Maryland has been assigned a patent (No. US 12582691 B2, initially filed July 12, 2022) developed by Guoqiang Xing, Gaithersburg, Maryland, and Xiaodong Ma, Beijing, China, for "Administration of Yunnan Baiyao or Xingnaojing in patients with moderate-to-severe traumatic brain injury and craniotomy." . . .
